Oxford and Cheltenham, United Kingdom
Senior Research Fellow
MRC Population Health Research Unit, Nuffield Department of Population Health, University of Oxford
Consultant Vascular Surgeon
Cheltenham General Hospital
SCHEDULE FOR VEITHsymposium™
Wednesday, November 17, 2021
Presenter
SESSION 23: GENERALITIES IN THE ENDOVASCULAR AND OPEN TREATMENT OF LOWER EXTREMITY OCCLUSIVE DISEASE AND CLTI (5 AND 4 ¾-MINUTE SHORT SUMMARY [SS] TALKS)
Statins Decrease Rates Of Mortality, Amputation, MACE And Strokes And Increase Procedural Patency Rates In CLTI Patients: What Is The Best Drug And Dose
6:52 AM - 6:57 AM
Presenter
SESSION 31: ADVANCES IN MEDICAL TREATMENTS, NEW ANTI-ATHEROGENIC DRUGS, VALUE OF RIVAROXABAN AND PREVENTING MIS IN VASCULAR SURGERY PATIENTS
New Adjunctive Drugs (Plus Statins) To Lower LDL-Cholesterol (LDL-C) In Vascular Patients: Inclisiran, Bempedoic Acid And Ezetimbe: How Do They Work And When And How To Use Them: Level Of LDL-C To Strive For
7:28 AM - 7:33 AM
Friday, November 19, 2021
Presenter
SESSION 83: MORE HOT CAROTID TOPICS: UPDATES ON KEY CAROTID RCTS; NEW INFORMATION ON TREATMENT OF TANDEM LESIONS, CAROTID ANEURYSMS AND STROKES DURING INTERVENTION
Update On ACST 2: CEA Versus CAS For ACS: What Is It Telling Us And When Will We Have All The Answers
1:00 PM - 1:05 PM
Presenter
SESSION 93: NEW DEVELOPMENTS IN MEDICAL AND DRUG TREATMENTS: BEST ANTIPLATELET REGIMENS; UPDATE ON RARE VASCULAR DISEASES
Lowering LDL-C And Controlling Elevated Blood Pressure Can Lower Cardiovascular Risk 80%: Doing These Things Should Be A Lifetime Goal
3:36 PM - 3:41 PM
 
previous next